ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 680

$660K Total Retail Price of All Prescriptions

Rank: 179 out of 680

567 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 526 513 1 6
AMLODIPINE BESYLATE 449 408 2 1
LISINOPRIL 438 421 3 5
HYDROCODONE-ACETAMINOPHEN 423 320 S3 4 4
METFORMIN HCL 368 332 5 8
OMEPRAZOLE 362 347 6 7
LOVASTATIN 356 334 7 44
HYDROCHLOROTHIAZIDE 327 310 8 9
LEVOTHYROXINE SODIUM 321 270 9 2
CITALOPRAM HBR 302 280 10 22
SIMVASTATIN 274 242 11 3
METOPROLOL SUCCINATE 234 202 12 13
ZOLPIDEM TARTRATE 233 196 13 17
POLYETHYLENE GLYCOL 3350 218 195 14 62
ALENDRONATE SODIUM 210 205 15 32
PRAVASTATIN SODIUM 200 173 16 10
GABAPENTIN 187 172 17 15
ATENOLOL 178 177 18 19
NEXIUM 171 166 19 16
WARFARIN SODIUM 169 165 20 20
POTASSIUM CHLORIDE 164 150 21 14
KLOR-CON M20 154 145 22 61
DIOVAN 151 151 23 31
NAMENDA 151 144 23 35
ALLOPURINOL 142 109 25 33
ETODOLAC 141 141 26 206
ATORVASTATIN CALCIUM 135 121 27 11
DONEPEZIL HCL 133 133 28 27
CARVEDILOL 130 130 29 23
RANITIDINE HCL 126 126 30 56
BENAZEPRIL HCL 117 93 31 40
DOXAZOSIN MESYLATE 117 102 31 73
CLOPIDOGREL 109 96 33 26
METOPROLOL TARTRATE 100 93 34 12
PAROXETINE HCL 100 78 34 76
SERTRALINE HCL 100 94 34 28
PLAVIX 98 89 37 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 97 38 37
LANTUS SOLOSTAR 94 89 39 84
ACETAMINOPHEN-CODEINE 80 79 S3 40 175
LACTULOSE 79 78 41 92
EVISTA 77 77 42 135
NOVOLIN R 75 75 43 113
FAMOTIDINE 74 74 44 89
TAMSULOSIN HCL 74 73 44 34
DIGOXIN 73 73 46 58
TRAZODONE HCL 71 49 47 48
PREDNISONE 66 54 48 50
OXYBUTYNIN CHLORIDE 66 66 48 129
LIPITOR 65 54 50 68
HUMALOG 64 62 51 196
GLIMEPIRIDE 63 60 52 29
EXELON 61 58 53 112
ENALAPRIL MALEATE 61 61 53 65
CLONIDINE HCL 61 54 53 36
TRAMADOL HCL 59 47 56 18
CRESTOR 57 39 57 25
NIFEDIPINE ER 56 56 58 75
CYMBALTA 54 54 59 46
BYSTOLIC 54 53 59 79
QUINAPRIL HCL 51 51 61 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.